A New York Times investigation reported that in early studies of lecanemab (Leqembi) and donanemab (Kisunla), participants were not given the opportunity to know whether they carried APOE4, a genetic ...
In this Science segment, we examine the European Medicines Agency's recent decision to recommend granting marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback